It was also found that the preoperative concentrations of VEGF (median: 144.98 pg/mL) and CA 15-3 (23.88 U/mL) in patients with stage II BC were significantly higher in comparison to the healthy controls (p = 0.014, p = 0.001, respectively). The gene discussed is VEGFA; the disease is breast cancer.